SCHEMBL5087355

SCHEMBL5087355

Nc1ccc(OCc2cc(F)ccc2Cl)cc1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1C Q13936 1/20 0.48
RAB9A P51151 1/20 0.40
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
NR4A1 P22736 1/20 0.39
HTR2A P28223 4/20 0.39
SLC6A4 P31645 4/20 0.39
KCNH2 Q12809 3/20 0.39
MPO P05164 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAOB P27338 6/20 0.38
SCN5A Q14524 1/20 0.37
SCN9A Q15858 1/20 0.37
GRM5 P41594 1/20 0.37
SGMS2 Q8NHU3 1/20 0.37
ADAMTS4 O75173 1/20 0.36
MMP2 P08253 1/20 0.36
MMP13 P45452 1/20 0.36
MMP14 P50281 1/20 0.36
ADAMTS5 Q9UNA0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5095839 0.84 TSHR (0.47) NR4A1CYP3A4MAOBINPPL1
SCHEMBL21340749 0.84 MAOB (0.56) CACNA1CRAB9AALOX5APFEN1HTR2A
SCHEMBL13577170 0.84 CACNA1C (0.60) CACNA1CRAB9AHTR2ASLC6A4KCNH2
SCHEMBL5095849 0.81 MAOB (0.55) CACNA1CNR4A1MAOB
SCHEMBL4638661 0.81 MAOB (0.50) CACNA1CRAB9AALOX5APFEN1MPO
SCHEMBL810264 0.79 SLC6A2 (0.43) CACNA1CALOX5APFEN1SLC6A4MAOB
SCHEMBL22874660 0.78 FFAR1 (0.49) CACNA1CRAB9AHTR2ASLC6A4KCNH2
SCHEMBL13577174 0.76 TSHR (0.52) NR4A1CYP3A4MAOBINPPL1
SCHEMBL5090273 0.76 MAOB (0.66) RAB9AMAOB
SCHEMBL5095940 0.75 KCNQ2 (0.52) CACNA1CKCNH2CYP3A4MAOBSCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNJ2, KCNA2 CACNA1C 71/4885RAB9A 1165/4885ALOX5AP 1522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.